WHOOP at Ulta, Dermalux and the Science of Beauty Formulation

A beauty retailer is making room for a wearable. A professional skin care brand is taking its home device beyond the face. And ingredient suppliers are working on the parts of beauty you actually feel. This week, the interesting question is what happens around the product: before you choose it, while you use it, and between visits.

I'm Mike, and this is Beauty Tech Weekly. Today: WHOOP and Ulta, a new Dermalux device, Clariant's approach to sunscreen formulation, Meiyume's upcoming beauty showcase, and Dow's work on textures. Let's look at what was announced, what still needs to be demonstrated, and what these stories could mean for a beauty business.

WHOOP and Ulta Beauty announced a partnership on November third. WHOOP 5.0 and WHOOP MG are planned for Ulta's website and selected US stores from March 2027. These are existing devices entering a new retail channel. So the news is the partnership and its future rollout, rather than a new wearable launching this week.

What interests me is the shopping context. Someone entering a beauty store may now encounter a product built around daily habits, alongside the products they already associate with appearance and self-care. I see that as a useful signal about how retailers want to broaden the conversation. It gives a beauty business another reason to think about the customer's routine beyond the moment of purchase.

There is a practical challenge here. A device can require setup, learning and an ongoing reason to use it. Putting it on a shelf is only the beginning. If I were planning a launch like this, I would want the customer journey to explain the first week clearly: what happens after purchase, where help comes from, and how the customer knows whether the product fits their routine.

For salons, my takeaway is about service design. What does a client need to understand after leaving the building? Which questions are likely to appear at home? Those are useful questions even if your business never sells a wearable. We will have to wait for the retail rollout to see how this particular partnership handles that experience. For now, it is a distribution announcement with an interesting direction.

Dermalux has announced a home LED device for the neck and upper chest. The official release appeared on November sixth, following trade coverage earlier in the week. The company describes a ten-minute treatment using red and near-infrared light. This extends its home range to another area of the body, with a design intended to keep a controlled distance between the lights and the skin.

In the official product images, you can see the device worn around the neck and upper chest, with a separate controller. The second image shows its illuminated inner surface. These pictures help explain the shape and placement. They do not demonstrate a treatment result. Claims about skin improvement still need to be assessed against the evidence for the specific device, its instructions and the person using it.

For a salon owner, the bigger question is how home care fits into the relationship. A client leaves with a product or a device, but may still need help understanding the routine, knowing whom to contact, or arranging the next conversation. I think that makes the period between visits part of the service itself. The experience continues after the appointment has finished.

That's also what we're working on at AI Beauty Bot: helping salons use AI to stay in touch with clients between visits. A question can come up long before the next appointment, and the salon can remain part of that conversation. With home care becoming part of the story, I think continuity matters: clients should know how to reach their salon when they need it.

My practical takeaway would be to look at the follow-up experience around any home-care recommendation. Is the next step clear? Can the client easily ask a question? Is there a sensible route back to the professional when individual guidance is needed? That is where I would start. The technology in a device is one part of the experience; the communication around it deserves just as much thought.

Clariant's November third announcement focuses on a hybrid sunscreen ingredient system called Eclipsogen CAP Duo Z. The company describes a prepared dispersion that combines organic UV filters with zinc oxide and can be processed without heating. This is an input for formulators. It is not a finished sunscreen that a customer can buy, and it does not give every resulting product the same protection or feel.

The interesting part for me is the work behind a formula. A product brief might ask for a particular texture, appearance and application experience, but somebody has to make those requirements work together. A prepared ingredient system is one way a supplier tries to reduce that development work. The relevant business question is whether it helps a team make a better product reliably, in its own formulation and process.

Clariant reports test results for its system, but those results come with specific formulations and test conditions. I would keep that distinction visible. If I were evaluating a finished product built with a new ingredient, I would ask for evidence on that finished formula. A supplier's technical result is a starting point for a conversation, not a shortcut around checking the product that eventually reaches the customer.

For beauty businesses, this is a reminder to ask more than which fashionable ingredient is inside. What does the finished formula do? How does it apply? How does it fit the intended use? Those questions give a purchasing or development team something concrete to assess. My interest in this announcement is the attempt to make formulation work simpler, while the final product still has to earn its own claims.

Meiyume announced BEACON ahead of Cosmopack Asia, which is scheduled for November tenth to twelfth in Hong Kong. Its presentation connects beauty trend intelligence with formulation, packaging and manufacturing. The company's Beauty Intelligence Platform already existed before this week. The fresh news is the upcoming showcase and how Meiyume plans to bring those capabilities together. At our editorial cutoff, the event has not happened yet.

What I would want to see is the path from an interesting trend to an actual development decision. Which customer is the product for? Which problem does it solve? Why this formula and this pack? A convincing demonstration should make those decisions easier to follow. A dashboard full of signals can be useful, but the value becomes much clearer when a team can explain what it changed because of them.

So I am treating this as a preview to watch, rather than a claim that AI has already transformed the process. The useful follow-up would be a concrete example, with enough detail to understand the decisions and the limits. For a brand owner, that is a good standard to bring to any technology presentation: show how the information changes the work.

Dow's November announcement brings together four functional ingredients and four formulation concepts for in-cosmetics Asia. The lineup includes an elastomer blend, an oil gellant and two emollients. One detail matters for the timeline: the oil gellant, DOWSIL 8190, was already documented earlier this year. We are covering the November presentation and its formulation ideas, without treating every ingredient as a first-ever launch.

The ingredient names can sound abstract, so here is the practical connection. Dow describes tools for shaping texture, structuring oils and changing how a formula spreads and feels. Think about the questions a development team might ask: does it hold the intended form, does it move easily during application, and what remains afterwards? Our graphic is an editorial explanation of those questions, not footage of a product test.

I would want to compare prototypes in a defined use case. What changed in the formula? What trade-offs came with that change? And how does the team judge the experience? A phrase like silky or lightweight is a useful ambition, but it is also something people may interpret differently. Giving a development team a clear comparison is more useful than asking it to deliver a list of attractive adjectives.

This is why ingredient stories belong in a beauty technology conversation. Some of the most relevant work happens in the feel of a product, even when there is no screen or app involved. For a salon choosing retail products, my takeaway is to ask suppliers to explain the practical difference in the finished formula, and make that difference understandable to the person who will use it at home.

Across these five stories, I see a common question: how does the technology fit into someone's actual experience? Ulta and WHOOP will need to explain a new retail journey. Home devices raise questions about support between visits. Ingredient systems still need to become good finished products. And AI tools need to connect information with decisions. That is the level where I would judge the value: what becomes clearer, easier or more useful?

Which of these would make the biggest difference in your business: a new retail category, a better home-care conversation, or a better product formula? Let me know. I'm Mike, and this was Beauty Tech Weekly. See you in the next episode.